Chronic Endometritis Antibiotics: What Clears It, Why the Retest Matters More Than the Prescription, and What to Do If It Comes Back Positive
- 5 hours ago
- 11 min read
Quick answer: Chronic endometritis antibiotics work, and they work well — a single two-week course clears the inflammation in roughly three out of four to four out of five women. But the prescription is only half of the treatment. What predicts pregnancy is not that you took the antibiotics; it is that a repeat biopsy confirms the inflammation is gone. Women whose chronic endometritis is confirmed cured have far higher ongoing pregnancy and live birth rates than women whose inflammation quietly persists. And if the first course does not clear it, a second or third course usually does. At Rejuvenating Fertility Center, that confirm-and-retreat loop is standard, not optional.
What Is Chronic Endometritis — and Why Does It Matter for Fertility?
How Chronic Endometritis Antibiotics Work — the Protocol Step by Step
What the Research Shows — Chronic Endometritis Antibiotics Outcomes
What If the Antibiotics Didn't Work? The Question Nobody Answers
Biopsy-Confirmed Treatment vs. Empiric Antibiotics — How to Decide
What Is Chronic Endometritis — and Why Does It Matter for Fertility?
You did everything right. The embryo was euploid. The lining measured beautifully. And the test was negative anyway — again. Nobody has been able to tell you why, and after the third or fourth time, "unexplained" starts to feel less like an answer and more like a shrug.
Chronic endometritis is one of the reasons that shrug is often wrong. It is a low-grade, persistent inflammation of the endometrium — the lining an embryo has to implant into. It rarely causes pain. It rarely causes obvious symptoms of any kind. It does not show up on a standard ultrasound, a hormone panel, or an HSG. The only way to find it is to look for it directly: an endometrial biopsy stained for CD138, a marker that lights up the plasma cells that should not be in a healthy lining.
The inflammation matters because it changes the endometrium's chemistry. An inflamed lining sends different signals, expresses different receptivity markers, and behaves differently toward an arriving embryo than a quiet one does. The embryo can be perfect and still find the door closed.
You should ask about testing if you have:
Two or more failed embryo transfers, especially with euploid (chromosomally normal) embryos
Two or more miscarriages, particularly early first-trimester losses
A diagnosis of unexplained infertility after a full workup came back normal
A history of prolonged or irregular menstrual bleeding, endometrial polyps, or retained products after a prior loss
Endometriosis, a history of pelvic infection, or prior tubal disease — see uterine and tubal health
How common is it? In a 2024 systematic review and meta-analysis, chronic endometritis was found in roughly 19% of women with infertility compared with 8% of controls, and in about 38% of women with recurrent pregnancy loss compared with 16% of controls (Ticconi et al., Frontiers in Immunology, 2024). Put plainly: if you have had repeated losses, there is a meaningful chance this is sitting in your chart untested.
Why Patients Ask About Chronic Endometritis Antibiotics
Because a treatable cause is a very different situation than an unexplained one
Chronic endometritis is one of the few findings in reproductive medicine where the fix is a two-week course of oral medication. That is a genuinely different conversation than "we don't know." Most of what makes implantation failure so heavy is the not-knowing. A CD138-positive biopsy replaces that with a target.
Because their clinic never tested for it
Testing for chronic endometritis requires a hysteroscopy and biopsy — an extra procedure, an extra pathology fee, an extra month. High-volume clinics often skip it and move straight to another transfer. RFC's Reproductive Immunology Program exists precisely because these hidden inflammatory and immune causes are worth the month it takes to find them.
Because they took doxycycline and it still didn't work
This is the most common version of the question, and the most important. Taking chronic endometritis antibiotics does not guarantee the inflammation cleared. Without a repeat biopsy, you have no idea which group you are in — and as the research below shows, that distinction is where nearly all of the benefit lives.
Because they want to know whether it explains the miscarriages too
It can. Chronic endometritis is associated with both implantation failure and recurrent early loss, and the same treatment pathway applies to both. It is also frequently found alongside other treatable findings — polyps, ovarian cysts, and endometriosis-related inflammation — which is why RFC evaluates the uterine environment as a whole rather than one finding at a time.
How Chronic Endometritis Antibiotics Work — the Protocol Step by Step
The mechanism is straightforward: the plasma cells in the lining reflect a persistent low-grade bacterial presence. Clear the organisms, and the plasma cell infiltrate resolves. The endometrium returns to a receptive baseline. Here is what the full sequence looks like:
Step 1 — Hysteroscopy and endometrial biopsy. An office procedure, usually in the proliferative phase. The hysteroscope also identifies micropolyps, hyperemia, and stromal edema — the visual signatures of chronic endometritis — and lets your physician remove polyps in the same sitting.
Step 2 — CD138 immunohistochemistry. Standard H&E staining misses cases. CD138 staining specifically marks plasma cells, which is why it has become the diagnostic reference for chronic endometritis.
Step 3 — Oral antibiotics, 14 days. Doxycycline alone is the most common first-line regimen. Levofloxacin combined with tinidazole is the main alternative.
Step 4 — The repeat biopsy. Performed in the first proliferative phase after treatment ends. This is the step that decides everything, and the step most often skipped.
Step 5 — Retreat if still positive, then transfer. A second and, if needed, third course. Transfer is scheduled once the lining tests clean.
Note what step 4 implies: the treatment is not "take antibiotics." The treatment is "reach a negative retest." Everything below explains why.
What the Research Shows — Chronic Endometritis Antibiotics Outcomes
Start with cure rates, because they are reassuring. In a randomized controlled trial of 172 women diagnosed by CD138, one course of antibiotics cleared the inflammation in 84.8% of the levofloxacin-plus-tinidazole group and 77.8% of the doxycycline-only group — a difference that was not statistically significant, while side effects were significantly more common with the combination (11.6% vs 2.3%) (Liu et al., American Journal of Obstetrics and Gynecology, 2026). The authors recommended doxycycline alone as first-line for exactly that reason: same result, easier on the patient.
Compare that to leaving it alone. In a randomized trial of 132 women, 89.3% of treated women converted to a negative CD138 retest, versus 12.7% of untreated controls (Song et al., Fertility and Sterility, 2021). Chronic endometritis does not reliably resolve on its own.
Now the part that changes how you should think about this. When researchers pooled 2,154 women across twelve studies, simply receiving antibiotics did not produce a statistically significant improvement in ongoing pregnancy or live birth compared with controls, though miscarriage rates were lower. But when they compared women whose chronic endometritis was confirmed cured against women whose inflammation persisted, the gap was dramatic: ongoing pregnancy/live birth odds were 6.82 times higher and clinical pregnancy odds 9.75 times higher in the cured group (Liu et al., Frontiers in Medicine, 2022). A separate meta-analysis of nine studies in recurrent implantation failure reached the same conclusion — benefit appeared only in women whose cure was verified on control biopsy (Cheng et al., Journal of Assisted Reproduction and Genetics, 2022).
This is also why some studies find no benefit at all from antibiotics: a meta-analysis that grouped all treated women together, cured and uncured alike, found no increase in implantation, pregnancy, or live birth rates (live birth OR 1.13) (Kato et al., Journal of Infection and Chemotherapy, 2022). The averaging hides the signal. The earlier landmark review said it first and said it plainly: a control biopsy should always confirm resolution before proceeding with IVF (Vitagliano et al., Fertility and Sterility, 2018).
Comparison group | Ongoing pregnancy / live birth | Clinical pregnancy | What it means for you |
Treated with antibiotics vs. untreated controls | No significant difference (P = 0.09) | No significant difference (P = 0.36) | The prescription alone is not the win |
Cured chronic endometritis vs. women who never had it | OR 1.57 | OR 1.56 | A cured lining performs at least as well as a normal one |
Cured vs. persistent chronic endometritis | OR 6.82 (P < 0.00001) | OR 9.75 (P < 0.00001) | Confirming the cure is the entire treatment |
Pooled data from 2,154 women across twelve studies (Liu et al., Frontiers in Medicine, 2022).
What If the Antibiotics Didn't Work? The Question Nobody Answers
Search this topic and you will find a dozen articles explaining what doxycycline is. Almost none tell you what happens when your retest comes back positive anyway. Here is that answer, because it is the one that actually determines your next cycle.
First: a positive retest is not a dead end. It is a dosing problem. In a case-control study of women treated with germ-directed antibiotic therapy, chronic endometritis was cured in 32.25% after one course, 62.5% after two courses, and 81.25% after three — leaving 18.75% persistent after three cycles (Cicinelli et al., Fertility and Sterility, 2021). Four out of five women who did not clear on the first course did clear with additional treatment. If your clinic treated once, retested, saw a positive result, and moved on to another transfer anyway, that is the gap to close.
Second: switching the regimen is a real option. Because doxycycline and the levofloxacin-tinidazole combination perform comparably as first-line therapy, a non-response to one is a reasonable prompt to try the other, sometimes with metronidazole added for anaerobic coverage. Your physician chooses based on your history, tolerance, and any culture or microbiome data available.
Third: refractory cases have additional pathways. Where oral therapy alone falls short, intrauterine approaches have been studied — one cohort combining oral antibiotics with intrauterine perfusion reported higher implantation, clinical pregnancy, and live birth rates in women with recurrent implantation failure and chronic endometritis (Ma et al., BMC Women's Health, 2023). Persistent inflammation is also a signal to widen the lens: RFC's Reproductive Immunology Program looks at endometrial immune markers and endometriosis-driven inflammation alongside CD138, and uterine rejuvenation addresses lining quality and implantation potential directly. One of the few reproductive immunologists in the country reads these cases here.
Fourth: the field is still refining this. A large multicentre, double-blind, placebo-controlled trial is currently randomizing women with recurrent miscarriage and chronic endometritis to doxycycline or placebo — the CERM trial, with up to 1,500 women planned across 29 UK hospital sites (Al-Memar et al., BMJ Open, 2023). Better answers are coming. Until they arrive, confirming the cure remains the most evidence-supported thing you can do.
Biopsy-Confirmed Treatment vs. Empiric Antibiotics — How to Decide
Some clinics skip the biopsy and prescribe antibiotics empirically after a failed transfer, on the theory that the medication is cheap and the procedure is not. The evidence does not support that shortcut.
Empiric antibiotics (no biopsy):
Faster and cheaper up front — no procedure, no pathology fee
In women with a prior failed euploid transfer and no histologic diagnosis, empiric treatment did not improve sustained implantation rates (Kuznetsov et al., Fertility and Sterility, 2018)
Leaves you with no baseline, so a repeat test cannot tell you anything
Exposes women who never had chronic endometritis to two weeks of antibiotics for no benefit
Biopsy-confirmed treatment:
Tells you whether the inflammation is actually there
Creates the baseline that makes the confirming retest meaningful
The hysteroscopy itself finds polyps, adhesions, and micropolyps that change the plan
Costs one extra month and one office procedure
The right choice depends on this: if you have had two or more failed transfers or two or more losses, the diagnostic path is worth the month. The benefit in mild chronic endometritis and severe disease alike depends on documenting the cure, and you cannot document a cure you never diagnosed. If you are under 40 with a first failed cycle and good reserve, a straightforward next transfer may be the better use of your time — our sister clinic Aurea Fertility handles those cases.
What to Expect — Costs, Timeline, and Next Steps
The full diagnose-treat-confirm loop typically runs two to three menstrual cycles. That is the honest timeline, and it is shorter than another failed transfer.
Stage | When | Typical US self-pay range |
Office hysteroscopy + endometrial biopsy | Cycle 1, proliferative phase | $800–$3,000 |
CD138 immunohistochemistry pathology | 7–14 days after biopsy | $150–$500 |
Oral antibiotic course (14 days) | Cycle 1–2 | $20–$120 |
Repeat biopsy to confirm cure | Cycle 2–3, proliferative phase | $400–$1,200 |
Ranges reflect typical US self-pay pricing and vary widely by region, facility, and insurance. For current RFC pricing, see affording care or ask our team directly.
What to request at your next appointment:
Hysteroscopy with endometrial biopsy and CD138 immunohistochemistry — name the stain, not just "biopsy"
A written plan for the repeat biopsy after treatment, scheduled before you start the antibiotics
Screening for endometrial polyps and retained tissue during the same hysteroscopy
Evaluation for co-existing endometriosis or immune findings if you have had multiple euploid failures
Questions worth asking your physician: How many CD138-positive cells per high-power field does your pathology lab use as the threshold? Will you retest me after treatment? If the retest is positive, what is course two? Live outside New York or Connecticut? Local monitoring lets you complete most of this near home and travel in only when needed, and RFC sees patients across Manhattan, Westport, Jericho, New Rochelle, and Brooklyn.
Frequently Asked Questions
How long do chronic endometritis antibiotics take to work?
The standard course is 14 days, and the repeat biopsy is performed in the first proliferative phase afterward — usually four to eight weeks from the start of treatment. In the randomized data, the large majority of treated women converted to a negative test after that single course (Song et al., Fertility and Sterility, 2021).
Is doxycycline or levofloxacin plus tinidazole better?
They perform comparably. The 2026 randomized trial found no significant difference in cure rate, and doxycycline alone caused significantly fewer side effects, which is why the authors recommended it as first-line. If doxycycline does not clear it, the combination regimen is a reasonable second course.
Can chronic endometritis go away on its own?
Rarely. In the untreated control arm of the randomized trial above, only about one in eight women converted to a negative test without treatment. This is a condition worth treating rather than waiting out.
Does mild chronic endometritis need treatment too?
Yes. In the subgroup analysis of the 2026 trial, cure rates were high for both mild chronic endometritis and severe disease, and the outcome benefit in the pooled data comes from reaching a negative retest regardless of starting severity.
What are the symptoms of chronic endometritis?
Usually none. Some women have prolonged periods, spotting between cycles, or mild pelvic discomfort, but most are entirely asymptomatic. That is exactly why it goes undiagnosed — the only reliable way to find it is CD138 staining on an endometrial biopsy.
Should I do another transfer while I wait for the retest?
That is a conversation to have with your physician, and it depends on your age, embryo supply, and how many transfers you have already had. What the evidence supports clearly is that transferring into a lining still testing positive is transferring into known inflammation. Our team will walk through the timing with you against your specific IVF protocol.
The Bottom Line
Chronic endometritis antibiotics work — but the retest is what turns treatment into a pregnancy. A single 14-day course clears the inflammation in most women, and when it does not, a second or third course usually finishes the job. What separates the women who go on to deliver from those who keep failing transfers is not the prescription; it is documented proof that the lining is clean before an embryo is placed into it.
If you have had repeated implantation failure or repeated losses and nobody has stained your endometrium for CD138, that is a testable, treatable gap in your workup — and it is exactly the kind of case Rejuvenating Fertility Center was built for. Reach out through our contact page or learn more about the physicians on our team. We will look at what has already been missed, and tell you what we can do about it.
